Login to Your Account

Biotech Stocks Drift Upward On ASH Meeting Anticipation

By Catherine Shaffer
BioWorld Today Contributing Writer

Monday, December 12, 2011
Stock in Ariad Pharmaceuticals Inc., Celgene Corp., YM Biosciences Inc. and other hemtaology-focused biotech companies trended upward Friday in anticipation of results presented over the weekend at the 53rd Annual American Society of Hematology meeting in San Diego.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription